Skip to search formSkip to main contentSkip to account menu

droloxifene

Known as: (E)--1-[4'-(2-dimethylaminoethyoxy)phenyl]-1(3-hydroxyphenyl)-2-phenyl-but-1-ene, (E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol, 3-hydroxytamoxifen 
A phenolic analogue of tamoxifen, a nonsteroidal selective estrogen receptor modulator (SERM). Droloxifene competitively inhibits the binding of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Highly Cited
2003
Highly Cited
2003
A series of ferrocene derivatives based upon the structure of the antiestrogenic drug tamoxifen or of its active metabolite… 
Highly Cited
1999
Highly Cited
1999
We used mouse hepatoma (Hepa1c1c7) cells to study the role of the serine/threonine kinase Akt in the induction ofGLUT1 gene… 
Review
1999
Review
1999
Highly Cited
1998
Highly Cited
1998
We have discovered a new, nonsteroidal, potent estrogen agonist/antagonist, CP-336,156. CP-336,156 binds selectively and with… 
Highly Cited
1997
Highly Cited
1997
PURPOSE Overexpression of the HER-2/c-neu/c-erbB2 proto-oncogene is associated with a worse prognosis in patients with breast… 
Highly Cited
1992
Highly Cited
1992
Chronic administration of tamoxifen to female rats causes hepatocellular carcinomas. We have investigated damage to liver DNA… 
Highly Cited
1989
Highly Cited
1989
The effects of tamoxifen, three of its in vivo metabolites and 3-hydroxytamoxifen on cellular proliferation and the induction of…